The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients

Blood

Volumn 81, Issue 5, 1993, Pages 1137-1145

  Chopra, R ^a   McMillan, A K ^a   Linch, D C ^a   Yuklea, S ^a   Taghipour, G ^a   Pearce, R ^a   Patterson, K G ^a   Goldstone, A H ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CHLORMETHINE; CYTARABINE; ETOPOSIDE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSENSITIVITY; DRUG MEGADOSE; DRUG RESISTANCE; DRUG RESPONSE; FEMALE; GENDER; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0027534424     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v81.5.1137.1137     Document Type: Article

References (0)